MasterPharm Recalls Minoxidil/Biotin/Spironolactone Capsules Due to Processing Controls
MasterPharm LLC is recalling Minoxidil/Biotin/Spironolactone capsules nationwide due to a lack of processing controls and assurance of conformity to specifications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score involving potential non-conformity without confirmed harm.
Plain-English summary
MasterPharm LLC is voluntarily recalling Minoxidil/Biotin/Spironolactone 1.25/5/25mg capsules, 90 capsules per bottle, in the United States. The recall was initiated because of a lack of processing controls, which means there is a lack of assurance that the product conforms to specifications.
The affected product is distributed nationwide. The specific lot codes and expiration dates involved are 01-16-2020:70@11 (BUD 7/14/2020) and 01-30-2020:87@9 (BUD 7/28/2020). The total quantity recalled is 1,200 capsules.
Consumers who have purchased these specific capsules should stop using them and contact MasterPharm LLC at (866) 630-5600 for further instructions or a refund.
The recalled product
- Product
- Minoxidil/Biotin/Spironolactone 1.25/5/25mg capsules, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
- Manufacturer
- MasterPharm LLC
- Category
- Drug — Oral Solid Dosage
- Affected units
- 1,200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- 01-16-2020:70@11
- BUD 7/14/2020 01-30-2020:87@9
- BUD 7/28/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 26 recalled by MasterPharm LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · MasterPharm LLC
See all →- ModerateMasterPharm Recalls Tadalafil 12 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82M Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
Same hazard · lack of processing controls
See all →- ModerateMasterPharm Recalls Vardenafil Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Yohimbine HCL Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
Similar recalls
- SevereMasterPharm Recalls Compounded Minoxidil, Biotin, and Spironolactone Capsules
FDA (Drugs) · 2020-07-08
- SevereMasterPharm Recalls Finasteride Plus Capsules Due to Minoxidil Contamination
FDA (Drugs) · 2020-05-20
- LowMicro Labs Recalls Simvastatin Tablets Due to Impurity Failure
FDA (Drugs) · 2015-03-18
- ModeratePfizer Recalls Aldactone Tablets Due to Unapproved Manufacturing Site
FDA (Drugs) · 2013-11-27
- ModerateBetahistine 16 mg Capsules Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateSandoz Recalls Nitrofurantoin Capsules Due to Cross Contamination
FDA (Drugs) · 2018-11-21